InsidersTradesSigma
Follow the 녹십자 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 녹십자 has logged 2 reports. Market capitalisation: €1,280.6bn. The latest transaction was disclosed on 22 June 2026 (Purchase). Among the most active insiders: 정재욱. Every trade is openly available.
Analysts rate 녹십자 Buy (bullish), based on 8 analysts. Average price target: ₩198,500.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
녹십자 es una empresa surcoreana especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XKRX.